• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-羟胺基-5-乙基-5-仲戊基巴比妥酸(HB-7)在两种癫痫实验模型中的抗惊厥作用。

Anticonvulsive effect of 2-hydroxylamine-5-ethyl-5-sec-pentyl barbituric acid (HB-7) in two experimental models of epilepsy.

作者信息

Getova D, Moyanova S

机构信息

Department of Experimental Pharmacology, Bulgarian Academy of Sciences, Sofia.

出版信息

Methods Find Exp Clin Pharmacol. 1988 Apr;10(4):267-72.

PMID:3386334
Abstract

The effects of barbiturate HB-7 (2-hydroxylamine-5-ethyl-5-sec-pentylbarbituric acid) injected intraperitoneally compared to the effects of pentobarbital and/or phenobarbital were investigated in three series of experiments on cats: normal electrocorticogram (ECoG); pentylentetrazol-induced generalized paroxysmal ECoG; and paroxysmal ECoG activity induced by topical application of penicillin on the exposed cortical surface. In the first series, HB-7 led to the appearance of ECoG spindles of the same type as those elicited by pentobarbital. In the second series (pentylentetrazol-treated group), HB-7 increased the two thresholds: one associated with the appearance of isolated paroxysmal spike-wave complexes and the other corresponding to the appearance of generalized paroxysmal ECoG activity. In the third series, HB-7 led to an inhibition of penicillin spikes, both in the focus itself and in the other cortical areas where they propagated. The possibility for using HB-7 as an antiepileptic drug was discussed.

摘要

在对猫进行的三组实验中,研究了腹腔注射巴比妥酸盐HB - 7(2 - 羟胺 - 5 - 乙基 - 5 - 仲戊基巴比妥酸)与戊巴比妥和/或苯巴比妥的作用相比的效果:正常脑电图(ECoG);戊四氮诱导的全身性阵发性ECoG;以及在暴露的皮质表面局部应用青霉素诱导的阵发性ECoG活动。在第一组实验中,HB - 7导致出现与戊巴比妥引起的相同类型的ECoG纺锤波。在第二组实验(戊四氮治疗组)中,HB - 7提高了两个阈值:一个与孤立的阵发性棘波 - 慢波复合波的出现相关,另一个与全身性阵发性ECoG活动的出现相对应。在第三组实验中,HB - 7导致青霉素棘波在其起源部位以及它们传播到的其他皮质区域均受到抑制。讨论了将HB - 7用作抗癫痫药物的可能性。

相似文献

1
Anticonvulsive effect of 2-hydroxylamine-5-ethyl-5-sec-pentyl barbituric acid (HB-7) in two experimental models of epilepsy.2-羟胺基-5-乙基-5-仲戊基巴比妥酸(HB-7)在两种癫痫实验模型中的抗惊厥作用。
Methods Find Exp Clin Pharmacol. 1988 Apr;10(4):267-72.
2
Anticonvulsive activity of a barbiturate derivative HB-7 in a model of allylglycine-induced epilepsy in cats.巴比妥类衍生物HB-7在猫烯丙基甘氨酸诱导的癫痫模型中的抗惊厥活性。
Acta Physiol Pharmacol Bulg. 1990;16(3):43-9.
3
GABA-ergic mechanisms in the anticonvulsive activity of newly synthesized barbiturates. II. Correlation of HB-7 with GABA-ergic agents.新合成巴比妥类药物抗惊厥活性中的γ-氨基丁酸能机制。II. HB-7与γ-氨基丁酸能药物的相关性。
Acta Physiol Pharmacol Bulg. 1988;14(2):49-55.
4
Antihypoxic effect of the hydroxylamine derivative HB-7.羟胺衍生物HB-7的抗缺氧作用
Acta Physiol Pharmacol Bulg. 1989;15(1):83-8.
5
Investigation of 2-hydroxylamino-5-ethyl-5-sec-pentylbarbituric acid for anxyolitic action.对2-羟氨基-5-乙基-5-仲戊基巴比妥酸抗焦虑作用的研究。
Acta Physiol Pharmacol Bulg. 1990;16(2):42-7.
6
Epileptogenic effect of intracortically applied kainic acid in cats.
Methods Find Exp Clin Pharmacol. 1985 Dec;7(12):611-6.
7
[Effect of gamma-amino-beta-hydroxybutyric acid (GABHB) on experimentally-induced epileptic activity].
Riv Neurol. 1980 Jul-Aug;50(4):253-68.
8
GABA-ergic mechanisms in the anticonvulsive activity of newly-synthesized barbiturates. I. Effects of barbiturates on the convulsive action of GABA-antagonists.新合成巴比妥类药物抗惊厥活性中的γ-氨基丁酸能机制。I. 巴比妥类药物对γ-氨基丁酸拮抗剂惊厥作用的影响。
Acta Physiol Pharmacol Bulg. 1987;13(3):43-50.
9
Anticonvulsant effects of melatonin on penicillin-induced epileptiform activity in rats.褪黑素对青霉素诱导的大鼠癫痫样活动的抗惊厥作用。
Brain Res. 2006 Jul 12;1099(1):183-8. doi: 10.1016/j.brainres.2006.04.093. Epub 2006 Jun 9.
10
[The effect of the newly synthesized barbiturate HB-7, phenobarbital and pentobarbital on the GABA content of the brain in rats].[新合成的巴比妥酸盐HB-7、苯巴比妥和戊巴比妥对大鼠脑内γ-氨基丁酸含量的影响]
Eksp Med Morfol. 1990;29(4):45-50.